271 related articles for article (PubMed ID: 24945268)
21. Topical use of phytotherapic cream (Capilen® cream) to prevent radiodermatitis in breast cancer: a prospective historically controlled clinical study.
Stefanelli A; Forte L; Medoro S; Sgualdo A; Lombardo D; Zini G; Maronta D; Rainieri E; Pascale G; Bagnolatti P; Colella M; Princivalle S; Fiorica F
G Ital Dermatol Venereol; 2014 Feb; 149(1):107-13. PubMed ID: 24566571
[TBL] [Abstract][Full Text] [Related]
22. Moisturizing cream ameliorates dryness and desquamation in participants not receiving topical psoriasis treatment.
Draelos ZD
Cutis; 2008 Sep; 82(3):211-6. PubMed ID: 18856161
[TBL] [Abstract][Full Text] [Related]
23. Thêta-Cream versus Bepanthol lotion in breast cancer patients under radiotherapy. A new prophylactic agent in skin care?
Röper B; Kaisig D; Auer F; Mergen E; Molls M
Strahlenther Onkol; 2004 May; 180(5):315-22. PubMed ID: 15127162
[TBL] [Abstract][Full Text] [Related]
24. Treating breast cancer radiotherapy-induced moist desquamation with a traditional Chinese medicine formula: a case series pilot study.
Xiaoshan W; Zhixi L; Liang L; Shuchun L; Xia W; Yuyi W; Feng L
J Altern Complement Med; 2014 Sep; 20(9):732-5. PubMed ID: 25046151
[TBL] [Abstract][Full Text] [Related]
25. Acute effects of postmastectomy radiotherapy after immediate TRAM flap reconstruction in breast cancer patients.
Sitathanee C; Puataweepong P; Swangsilpa T; Narkwong L; Kongdan Y; Suvikapakornkul R
J Med Assoc Thai; 2005 Dec; 88(12):1861-6. PubMed ID: 16518986
[TBL] [Abstract][Full Text] [Related]
26. Phase I study of topical epigallocatechin-3-gallate (EGCG) in patients with breast cancer receiving adjuvant radiotherapy.
Zhao H; Zhu W; Jia L; Sun X; Chen G; Zhao X; Li X; Meng X; Kong L; Xing L; Yu J
Br J Radiol; 2016; 89(1058):20150665. PubMed ID: 26607642
[TBL] [Abstract][Full Text] [Related]
27. A novel carbon-fibre adjustable reusable accessory (CARA) for supine breast positioning to reduce toxicity in breast adjuvant radiotherapy: a study protocol for a multicentre phase III randomized controlled trial.
Duzenli C; Chan EK; Bergman AM; Grahame S; Singer J; Burns L; Olson RA
BMC Cancer; 2022 Jun; 22(1):673. PubMed ID: 35725457
[TBL] [Abstract][Full Text] [Related]
28. Differences in the Acute Toxic Effects of Breast Radiotherapy by Fractionation Schedule: Comparative Analysis of Physician-Assessed and Patient-Reported Outcomes in a Large Multicenter Cohort.
Jagsi R; Griffith KA; Boike TP; Walker E; Nurushev T; Grills IS; Moran JM; Feng M; Hayman J; Pierce LJ
JAMA Oncol; 2015 Oct; 1(7):918-30. PubMed ID: 26247417
[TBL] [Abstract][Full Text] [Related]
29. Potent corticosteroid cream (mometasone furoate) significantly reduces acute radiation dermatitis: results from a double-blind, randomized study.
Boström A; Lindman H; Swartling C; Berne B; Bergh J
Radiother Oncol; 2001 Jun; 59(3):257-65. PubMed ID: 11369066
[TBL] [Abstract][Full Text] [Related]
30. Prophylactic treatment with a potent corticosteroid cream ameliorates radiodermatitis, independent of radiation schedule: A randomized double blinded study.
Ulff E; Maroti M; Serup J; Nilsson M; Falkmer U
Radiother Oncol; 2017 Jan; 122(1):50-53. PubMed ID: 27913066
[TBL] [Abstract][Full Text] [Related]
31. Topical use of recombinant human epidermal growth factor (EGF)-based cream to prevent radiation dermatitis in breast cancer patients: a single-blind randomized preliminary study.
Kong M; Hong SE
Asian Pac J Cancer Prev; 2013; 14(8):4859-64. PubMed ID: 24083759
[TBL] [Abstract][Full Text] [Related]
32. Granulocyte-Colony Stimulating Factor (G-CSF) accelerates healing of radiation induced moist desquamation of the skin.
Viswanath L; Bindhu J; Krishnamurthy B; Suresh KP
Klin Onkol; 2012; 25(3):199-205. PubMed ID: 22724569
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of a hydroactive colloid gel versus historical controls for the prevention of radiotherapy-induced moist desquamation in breast cancer patients.
Censabella S; Claes S; Orlandini M; Braekers R; Bulens P
Eur J Oncol Nurs; 2017 Aug; 29():1-7. PubMed ID: 28720256
[TBL] [Abstract][Full Text] [Related]
34. A Feasibility Study of Mepitel Film for the Prevention of Breast Radiation Dermatitis in a Canadian Center.
Yee C; Lam E; Gallant F; Karam I; Czarnota G; Soliman H; Wong G; Drost L; Vesprini D; Rakovitch E; Wronski M; Leung E; Szumacher E; Carothers K; Pon K; Gonzales G; Easton L; Lewis D; Zhang L; Chow E
Pract Radiat Oncol; 2021; 11(1):e36-e45. PubMed ID: 32949772
[TBL] [Abstract][Full Text] [Related]
35. Prophylaxis with a cream containing urea reduces the incidence and severity of radio-induced dermatitis.
Pardo Masferrer J; Murcia Mejía M; Vidal Fernández M; Alvarado Astudillo A; Hernández Armenteros ML; Macías Hernández V; Soto Pérez R; Mirada Ferre A
Clin Transl Oncol; 2010 Jan; 12(1):43-8. PubMed ID: 20080470
[TBL] [Abstract][Full Text] [Related]
36. Feasibility and acute toxicity of hypofractionated radiation in large-breasted patients.
Dorn PL; Corbin KS; Al-Hallaq H; Hasan Y; Chmura SJ
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):79-83. PubMed ID: 22035661
[TBL] [Abstract][Full Text] [Related]
37. Three-Arm Randomized Phase III Trial: Quality Aloe and Placebo Cream Versus Powder as Skin Treatment During Breast Cancer Radiation Therapy.
Hoopfer D; Holloway C; Gabos Z; Alidrisi M; Chafe S; Krause B; Lees A; Mehta N; Tankel K; Strickland F; Hanson J; King C; Ghosh S; Severin D
Clin Breast Cancer; 2015 Jun; 15(3):181-90.e1-4. PubMed ID: 25619686
[TBL] [Abstract][Full Text] [Related]
38. Randomized, Prospective, Open-label Phase III Trial Comparing Mebo Ointment With Biafine Cream for the Management of Acute Dermatitis During Radiotherapy for Breast Cancer.
Geara FB; Eid T; Zouain N; Thebian R; Andraos T; Chehab C; Ramia P; Youssef B; Zeidan YH
Am J Clin Oncol; 2018 Dec; 41(12):1257-1262. PubMed ID: 29889137
[TBL] [Abstract][Full Text] [Related]
39. Racial variations in radiation-induced skin toxicity severity: data from a prospective cohort receiving postmastectomy radiation.
Wright JL; Takita C; Reis IM; Zhao W; Lee E; Hu JJ
Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):335-43. PubMed ID: 25304794
[TBL] [Abstract][Full Text] [Related]
40. Optimal Topical Agent for Radiation Dermatitis During Breast Radiotherapy: A Pilot Study.
Fenton-Kerimian M; Cartwright F; Peat E; Florentino R; Maisonet O; Budin W; Rolnitzky L; Formenti S
Clin J Oncol Nurs; 2015 Aug; 19(4):451-5. PubMed ID: 26207710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
